ADM2 | Adrenomedullin 2 | | | | |
|
| | Tissue enhanced | 0 |
AFAP1L2 | Actin filament associated protein 1-like 2 | | | | |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
AL589739.1 | Uncharacterized protein | | | | | |
| | Tissue enhanced | 0 |
AP001350.1 | Uncharacterized protein | | | | | |
| | Tissue enhanced | 0 |
ATP13A4 | ATPase type 13A4 | | | | |
|
| | Tissue enhanced | 0 |
BMP7 | Bone morphogenetic protein 7 | | | | | |
| | Tissue enhanced | 0 |
BMP8B | Bone morphogenetic protein 8b | | | | |
|
| | Tissue enhanced | 0 |
C16orf89 | Chromosome 16 open reading frame 89 | | | | |
|
| | Tissue enhanced | 0 |
C3orf55 | Chromosome 3 open reading frame 55 | | | | |
|
| | Tissue enhanced | 0 |
CDON | Cell adhesion associated, oncogene regulated | | | | |
|
| | Tissue enhanced | 0 |
CNTN5 | Contactin 5 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
CNTN6 | Contactin 6 | | | | |
|
| | Tissue enhanced | 0 |
COL23A1 | Collagen, type XXIII, alpha 1 | | | | |
|
| | Tissue enhanced | 0 |
COL8A1 | Collagen, type VIII, alpha 1 | | | | |
|
| Vesicles | Tissue enhanced | 0 |
COL9A3 | Collagen, type IX, alpha 3 | | | | |
|
| Nucleus but not nucleoli Cytoskeleton (Intermediate filaments) | Tissue enhanced | 0 |
CRABP1 | Cellular retinoic acid binding protein 1 | | | | |
|
| | Tissue enhanced | 0 |
DCDC2 | Doublecortin domain containing 2 | | | | |
|
| | Tissue enhanced | 0 |
DGKI | Diacylglycerol kinase, iota | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
DIO2 | Deiodinase, iodothyronine, type II | | | | |
|
| | Tissue enhanced | 0 |
DMRT3 | Doublesex and mab-3 related transcription factor 3 | | | | |
|
| | Tissue enhanced | 0 |
DOCK3 | Dedicator of cytokinesis 3 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
DUOX1 | Dual oxidase 1 | | | | |
|
| | Tissue enhanced | 0 |
DUOXA1 | Dual oxidase maturation factor 1 | | | | |
|
| | Tissue enhanced | 0 |
EGR2 | Early growth response 2 | | | | | |
| | Tissue enhanced | 0 |
ENPP5 | Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | | | | |
|
| | Tissue enhanced | 0 |
ESM1 | Endothelial cell-specific molecule 1 | | | | |
|
| | Tissue enhanced | 0 |
ESYT3 | Extended synaptotagmin-like protein 3 | | | | |
|
| | Tissue enhanced | 0 |
FAM150A | Family with sequence similarity 150, member A | | | | |
|
| | Tissue enhanced | 0 |
FAM167A | Family with sequence similarity 167, member A | | | | |
|
| | Tissue enhanced | 0 |
FAM189A2 | Family with sequence similarity 189, member A2 | | | | |
|
| | Tissue enhanced | 0 |
FNDC1 | Fibronectin type III domain containing 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
FRAS1 | Fraser syndrome 1 | | | | |
|
| Nucleoli | Tissue enhanced | 0 |
FREM2 | FRAS1 related extracellular matrix protein 2 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
FRMPD3 | FERM and PDZ domain containing 3 | | | | |
|
| | Tissue enhanced | 0 |
GAL3ST3 | Galactose-3-O-sulfotransferase 3 | | | | | |
| | Tissue enhanced | 0 |
GLIS3 | GLIS family zinc finger 3 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
GOLGA8M | Golgin A8 family, member M | | | | |
|
| | Tissue enhanced | 0 |
GOLGA8O | Golgin A8 family, member O | | | | |
|
| | Tissue enhanced | 0 |
GOLGA8Q | Golgin A8 family, member Q | | | | |
|
| | Tissue enhanced | 0 |
GOLGA8R | Golgin A8 family, member R | | | | |
|
| | Tissue enhanced | 0 |
GPR83 | G protein-coupled receptor 83 | | | | |
|
| | Tissue enhanced | 0 |
GRID1 | Glutamate receptor, ionotropic, delta 1 | | | | | |
| | Tissue enhanced | 0 |
GRIN2C | Glutamate receptor, ionotropic, N-methyl D-aspartate 2C | | | | |
|
| | Tissue enhanced | 0 |
GRK1 | G protein-coupled receptor kinase 1 | | | | | |
| | Tissue enhanced | 0 |
HHEX | Hematopoietically expressed homeobox | | | | |
|
| | Tissue enhanced | 0 |
ID4 | Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | | | | |
|
| | Tissue enhanced | 0 |
INPP5J | Inositol polyphosphate-5-phosphatase J | | | | |
|
| Cytoplasm Nucleoli | Tissue enhanced | 0 |
IPCEF1 | Interaction protein for cytohesin exchange factors 1 | | | | |
|
| | Tissue enhanced | 0 |
IQCA1 | IQ motif containing with AAA domain 1 | | | | |
|
| | Tissue enhanced | 0 |
IRS4 | Insulin receptor substrate 4 | | | | |
|
| | Tissue enhanced | 0 |